Evonik Agrees to Buy Excipients Range from Boehringer Ingelheim

Evonik says it has agreed to purchase Boehringer Ingelheim’s  Resomer range of polymer-based pharmaceutical excipients. Financial terms were not disclosed. Completion of the transaction is subject to various conditions and closing is expected early March 2011, the companies say.   Under the agreement, the entire product portfolio of standard and customized polymers used in the manufacturing of medical devices and pharmaceutical formulations will be transferred to Evonik. Resomer polymers are based on lactic and glycolic acids and are fully...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers